Cutler Adam D.
- SEC CIK
- 0001722673
In the past year, 1 open-market sale filing worth $14.9K and no purchases.
Current role at each company
- MURA Mural Oncology plcChief Financial Officeras of Dec 5, 2025
- INM InMed Pharmaceuticals Inc.Directoras of Jan 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $14.9K
- 1 filing
- Net
- −$14.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cutler Adam D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MURA Mural Oncology plc
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 (view filing) | Nov 3 | 7 daysLate | Cutler Adam D.Chief Financial Officer | SSale | −7.15K | $2.09 | −$14.9K | −6.7%99.3K after | 10b5-1 |
| Nov 1, 2024 (view filing) | Oct 31 | 1 day | Cutler Adam D.Chief Financial Officer | SSale | −7.42K | $3.41 | −$25.3K | −9.4%71.4K after | 10b5-1 |